SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-197997
Filing Date
2018-06-20
Accepted
2018-06-20 16:34:58
Documents
3
Period of Report
2018-06-18
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d617552d8k.htm 8-K 17424
2 EX-4.1 d617552dex41.htm EX-4.1 63341
3 EX-10.1 d617552dex101.htm EX-10.1 21805
  Complete submission text file 0001193125-18-197997.txt   103717
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37708 | Film No.: 18909800
SIC: 2834 Pharmaceutical Preparations